Weight Loss Medications Linked to Divorce

Weight Loss Medications Linked to Divorce

Source: Fox News

Summary

Research suggests that weight loss, particularly through bariatric surgery or medications like GLP-1 receptor agonists, may increase the risk of divorce. A professor at the Institute of Health and Care Sciences in Sweden, Per-Arne Svensson, notes that significant weight loss can lead to changes in relationship dynamics, potentially causing friction and rifts in relationships. Historical data from bariatric surgery patients supports this theory, showing that patients who underwent surgery were twice as likely to get a divorce compared to the general population.


Our Reading

The advice sounds familiar.

We’ve seen this pattern before: a new weight loss method gains popularity, and concerns about its impact on relationships emerge. GLP-1 receptor agonists like Ozempic and Wegovy are no exception. As more people “take the jab” and experience significant weight loss, the social fallout is becoming increasingly apparent.

Per-Arne Svensson’s research highlights the link between weight loss and relationship status, warning that the social consequences of these medications are very real. He suggests that couples take a collaborative approach to health to mitigate the risk of a split.

The phenomenon of weight loss leading to relationship tension is not new, but the increasing popularity of these medications may make it more pronounced.

It seems that weight loss doesn’t have to mean “date loss,” but it can certainly mean “relationship reevaluation.

The same pattern that has been observed in bariatric surgery patients may be unfolding with GLP-1 receptor agonists, and it’s essential to acknowledge the potential social consequences of these medications.


Author: Evan Null